• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经活检证实的非酒精性脂肪性肝炎患者与非酒精性脂肪肝患者静息代谢率的比较。

The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients.

作者信息

Kenger Emre Batuhan, Guveli Hakan, Ergun Can, Kaya Eda, Yilmaz Yusuf

机构信息

Department of Nutrition and Dietetics, Bahcesehir University Faculty of Health Sciences, Istanbul, Turkey.

Istanbul University-Cerrahpasa, Istanbul, Turkey.

出版信息

Hepatol Forum. 2020 Jan 17;1(1):14-19. doi: 10.14744/hf.2020.0004. eCollection 2020 Jan.

DOI:10.14744/hf.2020.0004
PMID:35949663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9344366/
Abstract

BACKGROUND AND AIM

Resting metabolic (RMR) rate was shown to be associated with chronic inflammatory conditions. In this study, we aimed to investigate whether RMR differs significantly in patients with non-alcoholic steatohepatitis (NASH) from patients with non-alcoholic fatty liver disease (NAFLD) without evidence of inflammation.

MATERIAL AND METHODS

Forty-two biopsy-proven NASH were compared with 37 NAFLD patients, who had normal serum transaminases and no evidence of fibrosis based on transient elastography examination. In the interviews, patients' levels of physical activity and dietary habits were recorded, and bioimpedance analysis was performed. The RMRs were calculated using an indirect calorimeter.

RESULTS

RMR did not significantly differ between patients with NASH and NAFLD without steatohepatitis in both genders (p=0.695 in males, p=0.256 in females). However, only in female patients RMR rate per body weight was significantly higher in patients with NASH (22.3 [17.2-26.6] cal/kg to 20.2 [12.2-26.1] cal/kg, p=0.020).

CONCLUSION

In conclusion, RMR was not significantly associated with steatohepatitis in patients with NAFLD. Considering the minimizing the effects of body weight, RMR rate per body weight may be used over RMR in the evaluation of the inflammatory status of the NAFLD.

摘要

背景与目的

静息代谢(RMR)率已被证明与慢性炎症状态相关。在本研究中,我们旨在调查非酒精性脂肪性肝炎(NASH)患者的RMR与无炎症证据的非酒精性脂肪肝(NAFLD)患者相比是否存在显著差异。

材料与方法

将42例经活检证实的NASH患者与37例NAFLD患者进行比较,后者血清转氨酶正常,且基于瞬时弹性成像检查无纤维化证据。在访谈中,记录患者的身体活动水平和饮食习惯,并进行生物电阻抗分析。使用间接热量计计算RMR。

结果

NASH患者与无脂肪性肝炎的NAFLD患者的RMR在男女两性中均无显著差异(男性p = 0.695,女性p = 0.256)。然而,仅在女性患者中,NASH患者的每体重RMR率显著更高(22.3 [17.2 - 26.6] 千卡/千克对20.2 [12.2 - 26.1] 千卡/千克,p = 0.020)。

结论

总之,NAFLD患者的RMR与脂肪性肝炎无显著关联。考虑到尽量减少体重的影响,在评估NAFLD的炎症状态时,每体重RMR率可能比RMR更适用。

相似文献

1
The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients.经活检证实的非酒精性脂肪性肝炎患者与非酒精性脂肪肝患者静息代谢率的比较。
Hepatol Forum. 2020 Jan 17;1(1):14-19. doi: 10.14744/hf.2020.0004. eCollection 2020 Jan.
2
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.对肥胖症手术候选者的肝脂肪变性分级及非酒精性脂肪性肝炎检测中瞬时弹性成像、磁共振成像和血清评分的前瞻性比较
JHEP Rep. 2021 Sep 30;3(6):100381. doi: 10.1016/j.jhepr.2021.100381. eCollection 2021 Dec.
3
Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.评估中国代谢综合征与肝活检证实的非酒精性脂肪性肝炎之间的关系:一项多中心横断面研究设计
Adv Ther. 2016 Nov;33(11):2069-2081. doi: 10.1007/s12325-016-0416-4. Epub 2016 Oct 14.
4
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).丙氨酸氨基转移酶水平对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎(NASH)和肝纤维化的预测价值。
Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.
5
Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.脂肪肝进展算法和脂肪变性、活动度及纤维化评分在评估非酒精性脂肪肝对未经治疗的慢性乙型肝炎患者影响中的应用。
Front Cell Infect Microbiol. 2022 Jan 17;11:733348. doi: 10.3389/fcimb.2021.733348. eCollection 2021.
6
Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者非酒精性脂肪性肝炎诊断的超声检查指标
Quant Imaging Med Surg. 2022 Mar;12(3):1815-1829. doi: 10.21037/qims-21-895.
7
Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.经活检证实的非酒精性脂肪性肝病和非酒精性脂肪性肝炎在成年胆结石患者前瞻性队列中的患病率及危险因素
Liver Int. 2015 Aug;35(8):1983-91. doi: 10.1111/liv.12813. Epub 2015 Mar 5.
8
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.非酒精性脂肪性肝病全谱的代谢特征
JHEP Rep. 2022 Mar 26;4(5):100477. doi: 10.1016/j.jhepr.2022.100477. eCollection 2022 May.
9
CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.超声造影和瞬时弹性成像技术在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的应用
World J Hepatol. 2014 Jul 27;6(7):496-503. doi: 10.4254/wjh.v6.i7.496.
10
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.前瞻性评估大型美国中年队列中非酒精性脂肪性肝病和脂肪性肝炎的患病率。
J Hepatol. 2021 Aug;75(2):284-291. doi: 10.1016/j.jhep.2021.02.034. Epub 2021 Mar 18.

引用本文的文献

1
Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial.间歇性禁食对代谢功能障碍相关脂肪性肝病患者肝脏脂肪变性和纤维化、血清成纤维细胞生长因子21及自噬标志物的影响:一项随机对照试验
Life (Basel). 2025 Apr 25;15(5):696. doi: 10.3390/life15050696.
2
Changes in the etiology of chronic liver disease by referral to a FibroScan center: Increasing prevalence of the nonalcoholic fatty liver disease.转诊至FibroScan中心的慢性肝病病因变化:非酒精性脂肪性肝病患病率上升
Hepatol Forum. 2023 Jan 17;4(1):7-13. doi: 10.14744/hf.2022.2022.0042. eCollection 2023 Jan.
3

本文引用的文献

1
Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.土耳其非酒精性脂肪性肝病负担日益加重:单中心经验
Turk J Gastroenterol. 2019 Oct;30(10):892-898. doi: 10.5152/tjg.2019.19072.
2
Nonalcoholic Fatty Liver Disease and Obesity Treatment.非酒精性脂肪性肝病与肥胖症治疗。
Curr Obes Rep. 2019 Sep;8(3):220-228. doi: 10.1007/s13679-019-00345-1.
3
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.生活方式干预对非肥胖非酒精性脂肪性肝病患者的有益影响。
Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease.
肥胖合并代谢相关脂肪性肝病患者基于饮食的适度热量限制的可持续性
Hepatol Forum. 2021 Sep 15;2(3):97-101. doi: 10.14744/hf.2021.2021.0014. eCollection 2021 Sep.
4
Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic.Fibroscan 在评估肥胖患者肝脂肪变性和纤维化中的可行性:来自普通内科诊所的报告。
Turk J Gastroenterol. 2021 May;32(5):466-472. doi: 10.5152/tjg.2021.20498.
5
Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease.内脏脂肪面积和静息能量消耗在肥胖和非酒精性脂肪肝瘦患者代谢特征评估中的价值。
Turk J Gastroenterol. 2021 Feb;32(2):116-122. doi: 10.5152/tjg.2021.20908.
J Hepatol. 2018 Dec;69(6):1349-1356. doi: 10.1016/j.jhep.2018.08.011. Epub 2018 Aug 22.
4
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
5
Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter.表面健康的医学生中肝脂肪变性的患病率:基于受控衰减参数的瞬时弹性成像研究
Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1264-7. doi: 10.1097/MEG.0000000000000681.
6
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.生活方式改变对非酒精性脂肪性肝病的治疗作用:观察性研究与干预试验综述
Therap Adv Gastroenterol. 2016 May;9(3):392-407. doi: 10.1177/1756283X16638830. Epub 2016 Mar 17.
7
Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的营养与身体活动
J Diabetes Res. 2016;2016:4597246. doi: 10.1155/2016/4597246. Epub 2015 Dec 7.
8
NAFLD: a multisystem disease.非酒精性脂肪性肝病:一种多系统疾病。
J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012.
9
The impact of cryopreservation on human peripheral blood leucocyte bioenergetics.冷冻保存对人外周血白细胞生物能量学的影响。
Clin Sci (Lond). 2015 May 1;128(10):723-33. doi: 10.1042/CS20140725.
10
Energy expenditure in the critically ill performing early physical therapy.危重症患者进行早期物理治疗的能量消耗。
Intensive Care Med. 2014 Apr;40(4):548-55. doi: 10.1007/s00134-014-3218-7. Epub 2014 Jan 30.